Czech National Bank Bio Techne Corp Transaction History

Czech National Bank

$10.7 Billion
Q1 2025

A detailed history of Czech National Bank transactions in Bio Techne Corp stock. As of the latest transaction made, Czech National Bank holds 36,310 shares of TECH stock, worth $1.91 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

36,310

Previous 34,451 5.4%

Holding current value

$1.91 Million

Previous $2.48 Million 14.23%

% of portfolio

0.02%

Previous 0.02%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 Apr 09, 2025	BUY	$58.47 - $78.75 $108,695 - $146,396	1,859 Added 5.4%	36,310 $2.13 Million
Q4 2024 Jan 13, 2025	BUY	$66.37 - $78.17 $155,969 - $183,699	2,350 Added 7.32%	34,451 $2.48 Million
Q3 2024 Oct 03, 2024	BUY	$70.96 - $82.35 $147,029 - $170,629	2,072 Added 6.9%	32,101 $2.57 Million
Q2 2024 Jul 15, 2024	BUY	$62.12 - $84.15 $147,472 - $199,772	2,374 Added 8.58%	30,029 $2.15 Million
Q1 2024 Apr 10, 2024	SELL	$65.98 - $77.09 $2,837 - $3,314	-43 Reduced 0.16%	27,655 $1.95 Million
Q4 2023 Jan 08, 2024	BUY	$52.83 - $78.22 $9,562 - $14,157	181 Added 0.66%	27,698 $2.14 Million
Q3 2023 Oct 19, 2023	BUY	$67.52 - $89.42 $599,577 - $794,049	8,880 Added 47.65%	27,517 $1.87 Million
Q2 2023 Jul 11, 2023	BUY	$73.76 - $85.98 $8,039 - $9,371	109 Added 0.59%	18,637 $1.52 Million
Q1 2023 Apr 17, 2023	BUY	$71.62 - $86.62 $11,029 - $13,339	154 Added 0.84%	18,528 $1.37 Million
Q4 2022 Jan 18, 2023	BUY	$80.67 - $352.29 $1.11 Million - $4.87 Million	13,818 Added 303.29%	18,374 $0
Q3 2022 Oct 31, 2022	BUY	$282.54 - $391.85 $1.29 Million - $1.79 Million	4,556 New	4,556 $1.29 Million

Others Institutions Holding TECH

# of Institutions

616

Shares Held

154M

Call Options Held

161K

Put Options Held

12.7K

View Full List

About BIO-TECHNE Corp

Ticker TECH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 39,222,600
Market Cap $2.06B
Description
Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research and clinical diagnostic markets worldwide. The company operates through two segments, Protein Sciences, and Diagnostics and Genomics. The Protein Sciences segment develops and manufactures bi...

More about TECH

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Czech National Bank, based on Form 13F filings with the SEC.

News

Stay updated on Czech National Bank with notifications on news.

Account

Czech National Bank Bio Techne Corp Transaction History